Feosol (Carbonyl Fe)

Medically reviewed by
...
Views
Read Time

Drug Overview

Feosol (Carbonyl Fe) is a foundational medication within the hematology category, offering a highly specialized approach to mineral replacement. Classified as an Iron Supplement (Carbonyl Iron), it is designed to safely and effectively treat patients suffering from low red blood cell counts due to iron depletion. While the Feosol brand manufactures several types of iron, this specific “Carbonyl” formulation is unique. It is not an iron salt; rather, it consists of microscopic particles of nearly 100 percent pure elemental iron. This design makes it significantly gentler on the digestive system and inherently safer regarding accidental overdose compared to traditional iron pills.

  • Generic Name / Active Ingredient: Carbonyl iron
  • US Brand Names: Feosol (Carbonyl Iron formulation)
  • Drug Class: Iron Supplement (Carbonyl Iron)
  • Route of Administration: Oral (caplet or tablet)
  • FDA Approval Status: Fully FDA-approved and available over-the-counter for the management of iron deficiency.

    Find essential facts on Feosol (Carbonyl Fe). Discover its specific medical uses, health benefits, potential side effects, and precise dosage.

What Is It and How Does It Work? (Mechanism of Action)

Feosol Carbonyl Fe image 1 1 LIV Hospital
Feosol (Carbonyl Fe) 2

To understand how Carbonyl Iron works, it helps to understand how the body manufactures blood. Inside your bones is a spongy factory called bone marrow. To build healthy red blood cells, this factory needs specific raw materials, primarily iron. Iron is the essential building block for hemoglobin, the protein inside red blood cells responsible for grabbing oxygen in the lungs and delivering it to tissues throughout the body.

Unlike traditional iron salts (like ferrous sulfate), which dissolve immediately in the stomach and often cause severe irritation, carbonyl iron works through a more controlled biological process. When a patient swallows a Feosol Carbonyl caplet, the microscopic, uncharged iron particles enter the stomach. They must interact with the body’s natural stomach acid (hydrochloric acid) to be slowly dissolved and converted into the active, absorbable ferrous (Fe2+) ion form.

Because this conversion relies entirely on stomach acid, the iron is released gradually. This creates a natural “slow-release” effect. Once converted, the iron moves into the small intestine, where it is absorbed into the bloodstream. It binds to a transport protein called transferrin, which delivers it directly to the bone marrow. The developing red blood cells take in this iron to create fresh, oxygen-rich hemoglobin, effectively correcting the anemia from the inside out while minimizing gastrointestinal shock.

FDA-Approved Clinical Indications

Primary Indication

The primary clinical indication for Feosol (Carbonyl Fe) is the treatment and prevention of Iron Deficiency Anemia (IDA). It is heavily utilized to replenish empty iron stores in patients whose bodies lack the necessary materials to produce enough healthy red blood cells. It is frequently recommended for women experiencing heavy menstrual bleeding, patients recovering from surgery or blood loss, and individuals with chronically poor dietary iron intake.

Other Approved & Off-Label Uses

  • Pregnancy Iron Support: Highly recommended for pregnant women who require significant amounts of iron to support the developing baby and expanded maternal blood volume, particularly because the carbonyl form causes less nausea.
  • Frequent Blood Donors: Used as a safe, daily supplement to help regular blood donors rebuild their deep-tissue iron stores.
  • Erythropoiesis-Stimulating Agent (ESA) Support: Used to provide the bone marrow with raw iron while a patient receives kidney medications that stimulate red blood cell production.

Dosage and Administration Protocols

Because carbonyl iron is nearly 100 percent pure elemental iron, the milligram dosage on the bottle reflects the exact amount of iron the body is receiving, which makes dosing highly efficient. Feosol Carbonyl is typically manufactured in 45 mg caplets.

Patient PopulationStandard DoseFrequencyRoute of Administration
Adults (Treatment of Anemia)45 mg to 90 mg1 to 2 times dailyOral
Adults (Prevention/Maintenance)45 mgOnce dailyOral
Pregnant Women45 mg1 to 2 times dailyOral

Important Adjustments:

  • Alternate-Day Dosing: Modern hematology guidelines strongly suggest taking iron supplements every other day rather than every day. This prevents the liver from producing a blocking hormone called hepcidin, allowing the body to absorb the iron much more efficiently.
  • Gastric Acid Dependency: Because carbonyl iron strictly requires stomach acid to become absorbable, patients taking strong acid-reducing medications (like proton pump inhibitors or prescription antacids) may not absorb this specific formulation properly.
  • Vitamin C Pairing: Taking the medication with a glass of orange juice or a Vitamin C supplement increases the acidic environment in the stomach, dramatically boosting iron absorption.

Clinical Efficacy and Research Results

Clinical research consistently validates carbonyl iron as highly efficacious for treating iron deficiency anemia. Current data from 2020 through 2026 shows that carbonyl iron successfully raises hemoglobin levels at a rate comparable to traditional ferrous sulfate (roughly a 1 to 2 g/dL increase over 3 to 4 weeks). However, clinical trials heavily emphasize its superior tolerability profile. Studies demonstrate that patients taking carbonyl iron report up to a 50 percent reduction in severe gastrointestinal side effects like nausea and stomach pain. This increased tolerability leads to much higher patient compliance, meaning patients are far more likely to finish their months-long course of therapy and successfully cure their anemia.

Safety Profile and Side Effects

Black Box Warning

Feosol (Carbonyl Fe) carries the FDA’s strict Black Box Warning for pediatric iron toxicity. Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6 years of age. These medications must be kept out of the reach of children at all times. In case of an accidental overdose, call a doctor or poison control center immediately. (Note: While carbonyl iron has a much higher safety margin for overdose than iron salts due to its slow, acid-dependent absorption, it is still subject to this universal warning).

Common side effects (>10%)

  • Dark green or black-colored stools (a normal, harmless effect of unabsorbed iron)
  • Mild constipation (though significantly less frequent than with other iron types)
  • Mild stomach upset or nausea

Serious adverse events

  • Iron Overload (Hemochromatosis): In patients with undiagnosed genetic conditions that cause them to absorb too much iron, long-term supplementation can lead to toxic iron buildup in the liver and heart.
  • Severe Allergic Reactions: Extremely rare hypersensitivity to the caplet’s inactive ingredients.

Management Strategies

While constipation is reduced with carbonyl iron, patients are still encouraged to drink plenty of water, eat a high-fiber diet, and use a gentle over-the-counter stool softener if needed. To minimize any lingering stomach upset, patients can take the caplet with a small amount of food, although taking it on an empty stomach maximizes absorption. In the event of a severe overdose, emergency hospital care may involve gastric lavage or administering deferoxamine, an intravenous medication that binds to toxic iron in the blood.

Research Areas

Current hematology and gastroenterology research surrounding carbonyl iron is heavily focused on its interactions with modern stomach medications. As the global use of strong acid-reducing drugs (like omeprazole or pantoprazole) continues to rise, researchers are tracking how profoundly these drugs inhibit the absorption of acid-dependent iron formulations like carbonyl iron. Additionally, studies are actively comparing the long-term effectiveness of oral carbonyl iron against newer, single-dose intravenous (IV) iron infusions for patients suffering from severe inflammatory bowel diseases.

Disclaimer: These studies regarding carbonyl iron absorption during proton pump inhibitor use and comparisons of oral versus intravenous iron in inflammatory bowel disease are still evolving and are not yet applicable to practical or professional clinical scenarios. While reduced gastric acid can impair oral iron absorption and IV iron is often preferred in active IBD, claims of profound, uniform absorption inhibition or definitive long-term superiority of any single oral formulation remain exploratory and should be interpreted cautiously.

Patient Management and Practical Recommendations

Pre-treatment Tests

  • Complete Blood Count (CBC): To establish baseline hemoglobin and red blood cell sizes.
  • Comprehensive Iron Panel: Must include serum ferritin (the truest measure of deep-tissue iron stores), total iron-binding capacity (TIBC), and transferrin saturation.
  • Fecal Occult Blood Test: To ensure the anemia is not being caused by a slow, hidden bleed in the stomach or colon.

Precautions during treatment

  • Follow-Up Testing: A repeat CBC and reticulocyte count should be drawn 2 to 4 weeks after starting therapy to prove the bone marrow is responding and producing new red blood cells.
  • Stool Monitoring: Patients should be reassured that black stools are normal. However, if stools become sticky, tarry, or are accompanied by sharp abdominal pain, they must seek medical care to rule out a bleeding ulcer.

“Do’s and Don’ts” List

  • Do take your iron pill with water or a Vitamin C source (like orange juice) to help your body absorb it.
  • Do store the bottle securely, completely out of the sight and reach of young children and pets.
  • Do continue taking the medication for 3 to 6 months even after your energy returns, as it takes time to completely refill your body’s empty iron reserves.
  • Don’t take your iron pill at the exact same time as dairy products (milk, cheese) or calcium supplements, as calcium completely blocks iron absorption.
  • Don’t take this medication within two hours of taking antacids, thyroid medications (like levothyroxine), or certain antibiotics, as they will interact and render both medications useless.
  • Don’t assume all over-the-counter iron pills are the same; if your doctor specifically recommended carbonyl iron for its gentleness, do not substitute it for ferrous sulfate without asking.

Legal Disclaimer

For informational purposes only, does not replace professional medical advice from a qualified healthcare provider. This content is not intended to be a substitute for professional medical diagnosis, treatment protocols, or clinical judgment. Always seek the advice of your hematologist, primary care physician, or other qualified health provider with any questions you may have regarding anemia, iron supplementation, or before altering any medication regimen.

i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Trusted Worldwide
30
Years of
Experience
30 Years Badge
Health Türkiye Accreditation
Patient Reviews
Reviews from 9,651
4,9

Get a Free Quote

Response within 2 hours during business hours

Clinics/branches
GDPR
Was this content helpful?
Your feedback helps us improve.
What did you like?
Share more details about your experience.
You must give consent to continue.

Thank you!

Your feedback has been submitted successfully. Your input is valuable in helping us improve.

Our Doctors

Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu